SEK 7.0
(0.0%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 6.22 Million SEK | 72.33% |
2022 | 3.61 Million SEK | 12.9% |
2021 | 3.2 Million SEK | 200.56% |
2020 | 1.06 Million SEK | 51.28% |
2019 | 704 Thousand SEK | 200.57% |
2018 | -700 Thousand SEK | -566.67% |
2017 | -105 Thousand SEK | 86.4% |
2016 | -772 Thousand SEK | -77200100.0% |
2015 | 1.00 SEK | 0.0% |
2014 | 1.00 SEK | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 5.31 Million SEK | -20.39% |
2024 Q1 | 6.67 Million SEK | 7.19% |
2023 Q3 | 6.22 Million SEK | 50.33% |
2023 Q1 | 4.14 Million SEK | 14.64% |
2023 FY | 6.22 Million SEK | 72.33% |
2023 Q4 | 6.22 Million SEK | 0.0% |
2023 Q2 | 4.14 Million SEK | 0.0% |
2022 Q3 | 3.61 Million SEK | -2.46% |
2022 Q4 | 3.61 Million SEK | 0.0% |
2022 FY | 3.61 Million SEK | 12.9% |
2022 Q2 | 3.7 Million SEK | 0.0% |
2022 Q1 | 3.7 Million SEK | 15.75% |
2021 Q1 | 1.28 Million SEK | 20.56% |
2021 FY | 3.2 Million SEK | 200.56% |
2021 Q4 | 3.2 Million SEK | 0.0% |
2021 Q3 | 3.2 Million SEK | 149.3% |
2021 Q2 | 1.28 Million SEK | 0.0% |
2020 Q3 | 1.06 Million SEK | -20.76% |
2020 Q1 | 1.34 Million SEK | 90.91% |
2020 Q2 | 1.34 Million SEK | 0.0% |
2020 FY | 1.06 Million SEK | 51.28% |
2020 Q4 | 1.06 Million SEK | 0.0% |
2019 Q4 | 704 Thousand SEK | 0.0% |
2019 FY | 704 Thousand SEK | 200.57% |
2019 Q2 | -5.97 Million SEK | 0.0% |
2019 Q1 | - SEK | -100.0% |
2019 Q3 | 704 Thousand SEK | 111.78% |
2018 Q2 | -383 Thousand SEK | 0.0% |
2018 Q3 | 1.00 SEK | 100.0% |
2018 Q4 | 1.00 SEK | 0.0% |
2018 Q1 | - SEK | -100.0% |
2018 FY | -700 Thousand SEK | -566.67% |
2017 Q3 | 1.00 SEK | 100.0% |
2017 Q4 | 1.00 SEK | 0.0% |
2017 Q1 | - SEK | 100.0% |
2017 Q2 | -44 Thousand SEK | 0.0% |
2017 FY | -105 Thousand SEK | 86.4% |
2016 FY | -772 Thousand SEK | -77200100.0% |
2016 Q3 | - SEK | 0.0% |
2016 Q4 | -144 Thousand SEK | 0.0% |
2016 Q1 | - SEK | 0.0% |
2015 FY | 1.00 SEK | 0.0% |
2014 FY | 1.00 SEK | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
AroCell AB (publ) | 6.07 Million SEK | -2.586% |
Devyser Diagnostics AB (publ) | 20.6 Million SEK | 69.767% |
Immunovia AB (publ) | 1.00 SEK | -622799900.0% |
Prostatype Genomics AB (publ) | 203 Thousand SEK | -2967.98% |
Spermosens AB | -232 Thousand SEK | 2784.483% |